Royalty Pharma plc (NASDAQ:RPRX) Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants George Grofik - Senior Vice President, Head-Investor Relations & Communications Terry Coyne - Executive Vice President & Chief Financial Officer Marshall Urist - Head, Research & Investments Chris Hite - Vice Chairman Conference Call Participants Chris Schott - JPMorgan Terence Flynn - Morgan Stanley Chris Shibutani - Goldman Sachs Geoff Meacham - Bank of America Umer Raffat - Evercore Andrew Baum - ...

Royalty Pharma plc (NASDAQ:RPRX) Q4 2021 Earnings Conference Call February 15, 2022 8:00 AM ET Company Participants George Grofik – Senior Vice President, Head-Investor Relations and Communications Pablo Legorreta – Founder and Chief Executive Officer Jim Reddoch – Executive Vice President, Co-Head-Research and Investments and Chief Scientific Officer Marshall Urist – Executive Vice President, Co-Head of Research and Investments Terry Coyne – Executive Vice President and Chief Financial Officer Conference C ...

Royalty Pharma plc (NASDAQ:RPRX) Q3 2021 Results Conference Call November 10, 2021 8:00 AM ET Company Participants Pablo Legorreta â Founder and Chief Executive Officer Chris Hite â Vice Chairman Terry Coyne â EVP, Chief Financial Officer Jim Reddoch â EVP, Co-Head of Research and Investments and Chief Scientific Officer Marshall Urist â EVP, Co-Head of Research and Investments George Grofik â SVP, Head of Investor Relations and Communications Conference Call Participants Chris Schott â J.P. Morgan Andrew B ...

Royalty Pharma plc (NASDAQ:RPRX) Q2 2021 Earnings Conference Call August 11, 2021 8:00 AM ET Company Participants George Grofik - SVP & Head, IR & Communications Pablo Legorreta - Founder & CEO Jim Reddoch - EVP, Co-Head Research & Investments & CSO Marshall Urist - EVP & Co-Head, Research & Investments Terry Coyne - EVP & CFO Chris Hite - Vice Chairman Conference Call Participants Chris Schott - J.P. Morgan Bill Maughan - Bank of America Steve Scala - Cowen Terence Flynn - Goldman Sachs Umer Raffat - Everc ...

ROYALTY PHARMA ROYALTY PHARMA Royalty Pharma plc Q2 2021 Financial Results August 11, 2021 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. The information set forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are made ...

R □ YALTY PHARMA Royalty Pharma plc MorphoSys Transaction Advancing innovation with complete funding solutions June 2, 2021 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. The information set forth herein does not purport to be complete or to contain all of the information you may desire. Sta ...

ROYALTY PHARMA UBS Global Healthcare Conference Terrance Coyne, EVP, Chief Financial Officer Marshall Urist, EVP, Co-Head of Research & Investments May 24, 2021 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. The information set forth herein does not purport to be complete or to contain all o ...

ROYALTY PHARMA 7th Annual Truist Securities 2021 Life Sciences Summit Terrance Coyne, EVP, Chief Financial Officer Christopher Hite, EVP, Vice Chairman Jim Reddoch, EVP, Co-Head Research & Investments and Chief Scientific Officer May 20, 2021 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. Th ...

ROYALTY PHARMA Bank of America 2021 Healthcare Conference Terrance Coyne, EVP, Chief Financial Officer Marshall Urist, EVP, Co-Head Research & Investments May 12, 2021 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. The information set forth herein does not purport to be complete or to contai ...

PRE-QUARTERLY RESULTS COMMUNICATION NEW YORK, NY, April 14, 2021 - Royalty Pharma plc (Nasdaq: RPRX) intends to announce its financial results for the first quarter of 2021 on May 11, 2021. An invitation for the results webcast will follow shortly. To assist in the financial modeling of its first quarter 2021 results, the company has compiled the following items. Non-GAAP Financial Measures Royalty Pharma focuses on certain non-GAAP financial measures to manage its business. These measures, which are presen ...